Lipogems International spa   Report issue

For profit Phase 4
Founded: MIlan Italy (2010)
Status: No NME R&D (2010)

Organization Overview

First Clinical Trial
2017
NCT03117608
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Lipogems International spa

Active Ingredients

Drugs in Phase 4 Trials (2)

autologous adipose tissue (1 trial)

platelet-rich plasma (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Osteoarthritis (Phase 4)

Osteoarthritis, Knee (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 2